Literature DB >> 26304615

A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation.

Yan Chen1, Albert C Chan2, See-Ching Chan2, Siu-Ho Chok2, William Sharr2, James Fung2, Ju-Hua Liu1, Zhe Zhen1, Wai-Ching Sin1, Chung-Mau Lo2, Hung-Fat Tse3, Kai-Hang Yiu4.   

Abstract

BACKGROUND: Cirrhosis has been shown to be associated with left ventricular (LV) myocardial dysfunction, but studies of right ventricular (RV) function in cirrhotic patients compared with controls are scarce. Limited studies have prospectively evaluated the progression of myocardial function in patients with cirrhosis and assessed changes in cardiac function following liver transplantation (LTx). So the aim of the study was to evaluate biventricular myocardial function in cirrhotic patients and its alteration with or without liver transplantation.
METHODS: A total of 103 patients with cirrhosis (age 55±7 years, male 75%) were recruited. Conventional and 2-dimensional speckle tracking echocardiography was performed to determine the presence of LV and RV (biventricular) dysfunction. For comparison, 48 matched control subjects were included. Follow-up echocardiography was performed in 41 patients following LTx and in 26 patients who did not undergo LTx.
RESULTS: Patients with cirrhosis had biventricular dilatation, increased LV mass, impaired LV diastolic function, and biventricular systolic strain compared with controls. Following LTx, cirrhotic patients had reduced biventricular dilatation, a smaller LV mass, and improved biventricular systolic strain after a mean duration of 18.2±6.6 months. Patients who did not undergo LTx had a further increase in LV mass but no significant change in biventricular dimensions or systolic strain (mean duration of 20.4±8.3 months).
CONCLUSIONS: The present study demonstrates that patients with cirrhosis had biventricular dilatation and impaired biventricular systolic strain compared with controls. Following LTx, biventricular dilatation reduced and biventricular systolic strain improved. In contrast, patients who did not undergo LTx experienced a further increase in LV mass.
Copyright © 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac function; Cirrhosis; Liver transplantation

Mesh:

Year:  2015        PMID: 26304615     DOI: 10.1016/j.jjcc.2015.08.001

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  12 in total

1.  Cardiac changes in pediatric liver transplant recipients: are they truly irreversible?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2016-02-16       Impact factor: 6.047

2.  Redefining Cirrhotic Cardiomyopathy for the Modern Era.

Authors:  Manhal Izzy; Lisa B VanWagner; Grace Lin; Mario Altieri; James Y Findlay; Jae K Oh; Kymberly D Watt; Samuel S Lee
Journal:  Hepatology       Date:  2019-10-11       Impact factor: 17.425

3.  Exercise Performance in Pediatric Liver Transplant Recipients and Its Related Cardiac Function.

Authors:  Seyed Mohsen Dehghani; Mitra Moshref; Hamid Amoozgar; Seyed Ali Malek Hoseini; Saman Nikeghbalian
Journal:  Pediatr Cardiol       Date:  2017-12-14       Impact factor: 1.655

4.  Diagnosis and Management of Cirrhotic Cardiomyopathy.

Authors:  Harpreet Kaur; Madhumita Premkumar
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

5.  Systemic-to-pulmonary artery pressure ratio as a predictor of patient outcome following liver transplantation.

Authors:  Annette Rebel; Dung Nguyen; Brooke Bauer; Paul A Sloan; Amy DiLorenzo; Zaki-Udin Hassan
Journal:  World J Hepatol       Date:  2016-11-18

6.  In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival.

Authors:  Chien-Hao Huang; Lung-Sheng Wu; Wen-Juei Jeng; Yu-Fu Cheng; Yu-Shien Ko; I-Shyan Sheen; Chun-Yen Lin
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

7.  Intraoperative TOE guided management of newly diagnosed severe tricuspid regurgitation and pulmonary hypertension during orthotopic liver transplantation: a case report demonstrating the importance of reversibility as a favorable prognostic factor.

Authors:  B Pearce; R Hu; F Desmond; D Banyasz; R Jones; C O Tan
Journal:  BMC Anesthesiol       Date:  2019-07-13       Impact factor: 2.217

Review 8.  Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.

Authors:  Yannis Dimitroglou; Constantina Aggeli; Alexandra Alexopoulou; Sophie Mavrogeni; Dimitris Tousoulis
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

9.  Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification.

Authors:  Maurizio Cesari; Anna Chiara Frigo; Salvatore Piano; Paolo Angeli
Journal:  Clin Exp Hepatol       Date:  2021-08-23

Review 10.  Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.

Authors:  Pranab M Barman; Lisa B VanWagner
Journal:  Hepatology       Date:  2021-06       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.